logo
VIIth International Symposium on Viral Hepatitis: Summary
Hepatotropic viruses and autoimmunity 1997
The clinical significance of surface antigen variants of hepatitis B virus
Prolonged interferon-alpha therapy of hepatitis B virus-related decompensated cirrhosis
Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy
Interleukin-12: potential clinical applications in the treatment of chronic viral hepatitis
New therapies for chronic hepatitis B
Identification, prevalence and aspects of molecular biology of hepatitis G virus
A new hepatitis C virus-like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatase serum levels
HCV cDNA transfection to HepG2 cells
Investigation of the pattern of diversity of hepatitis C virus in relation to times of transmission
Development of a quantitative PCR assay for monitoring HCV viraemia levels in patients with chronic hepatitis C
Variables that influence response to different interferon schedules in chronic hepatitis C and predictive models
Interferon treatment of chronic hepatitis C with cirrhosis
Uncommon side-effects of interferon
Treatment of chronic hepatitis C with interferon: how long should a lasting response last if a lasting response could last?
A preliminary experience with GM-CSF plus interferon in patients with HBV and HCV resistant to interferon therapy
Liver transplantation for acute liver failure: outcome analysis
Hepatitis B virus and liver transplantation: concepts in antiviral prophylaxis
Morbidity and mortality of recurrent hepatitis C infection after orthotopic liver transplantation
Treatment of hepatocellular carcinoma